Page last updated: 2024-12-10

dipyrromethene

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

dipyrromethene: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

dipyrrin : A dipyrrin that consists of pyrrole bearing a pyrrol-2-ylidenemethyl substituent at the 2-position. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID3083424
CHEBI ID36318
MeSH IDM0494591

Synonyms (9)

Synonym
dipyrromethene
pyrromethene
CHEBI:36318
dipyrrin
2-(2h-pyrrol-2-ylidenemethyl)-1h-pyrrole
2-(1h-pyrrol-2-ylmethylidene)pyrrole
2-[(2h)-pyrrol-2-ylidene-methyl]-pyrrole
Q27116786
DTXSID301336447

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
" However, typical Bodipys are highly lipophilic, which often results in nonfluorescent aggregates in aqueous solution and also severely limits their bioavailability to cells and tissues."( Carbon-Dipyrromethenes: Bright Cationic Fluorescent Dyes and Potential Application in Revealing Cellular Trafficking of Mitochondrial Glutathione Conjugates.
Guo, W; Liu, J; Liu, M; Sun, YQ; Zhang, H, 2020
)
1.01
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
dipyrrinsCompounds containing two pyrrole rings linked through a methine group (-CH=).
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (152)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's23 (15.13)29.6817
2010's72 (47.37)24.3611
2020's57 (37.50)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 24.61

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index24.61 (24.57)
Research Supply Index5.04 (2.92)
Research Growth Index4.98 (4.65)
Search Engine Demand Index29.35 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (24.61)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews5 (3.27%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other148 (96.73%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]